CAS 2023788-19-2 Tirzepatide 99% Purity

Amy | Sales manager

Phone:+86 19142414382(whatsapp)

Email:shengzhikai3@shengzhikai.com

Address: 903, block B, Fortune Plaza, Luyang District, Hefei City, Anhui Province

Product Name Tirzepatide

CAS No. 2023788-19-2

MF C225H348N48O68

MW 4813.45

Appearance and shape White PowderTirzepatide is a novel, once weekly, dual GIP/GLP-1 receptor agonist and is under development for the treatment of type 2 diabetes (T2D) and obesity. 

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide-GLP-1 receptor agonist. Its structure is primarily based on the glucose-dependent insulinotropic polypeptide amino acid sequence and includes a C20 fatty diacid moiety. Its half-life of approximately 5 days allows once-weekly subcutaneous administration. A phase 2b trial involving patients with type 2 diabetes showed that those who received tirzepatide had dose-dependent reductions in the glycated hemoglobin level and weight at 26 weeks.

1.Diabetes Type 2 Medicine

2.Oral GLP-1RA Medication

3.Weight Loss

4.Diabetes Mellitus

5.Obesity

6.Diabetic Coma (in DM Type II)

7.Diabetic Ketoacidosis (in DM Type II)

8.Cardiovascular Risk Reduction

Packing and Delievery

Liquid 1L / Bottle, 25L/drum (5L, 10L all available)

Powder 1kg/ plastic bag, 25KG/drum (5kg, 10kg all available)

Basically, our product MOQ is 1KG/1L for testing.

Bulk price is much cheaper, due to 1L/1kg shipping fee is high.

25kg/Fiber drum , inner double plastic bags .

5kg/Aluminum foil bag 

1kg/Aluminum foil bag .

HOT SELLING 

CAS119276-01-6

1451-82-7

71368-80-4

23076-35-9    

157115-85-0

910463-68-2

2023788-19-2

CAS 2381089-83-2

28578-16-7

20320-59-6

5449-12-7

49851-31-2

52190-28-0

110-63-4

cas.1191237-69-0

cas171599-83-0

CAS79099-07-3 

 CAS2114-39-8 

 CAS2079878-75-2 

CAS7361-61-7